[ VitalConnect raises $33M in Series C ]
VitalConnect has raised $33 million in Series C funding.
Founded in 2011, VitalConnect develops a wearable biosensor technology that remotely monitors patients and provides diagnosis solutions for caregivers. The VitalPatch® wearable biosensor is a lightweight, wireless, adhesive patch that continuously monitors and records eight patient vital signs. The VitalConnect Platform integrates the VitalPatch biosensor with mobile and cloud-based software and analytics so patients can be monitored around the clock and across care settings.
The company will use the new financing to further commercialize its platform.
|City||San Jose, California|
|Founder / CEO||Nersi Nazari|
|MVM Life Science Partners|
|Previous Investors||Perceptive Advisors|